Our high-quality portfolio of comprehensive genomic profiling services provides powerful insights to help personalise treatment strategies
Molecular Testing and Molecular Insights leader Foundation Medicine provides powerful insights to help personalise treatment strategies. Contact for Foundationone Testing.
As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Together Roche and Foundation Medicine are bringing comprehensive genomic profiling to cancer patients around the world, combining Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation and experience in cancer profiling.
Comprehensive genomic profiling is a tumour testing method that utilizes next generation sequencing technology to identify all four classes of alterations across a large set of cancer-related genes (>50) known to drive cancer across tumour types.